Stockscreener 앱 받기
1.16
0.87%
0.01
시간 외 거래:
1.19
0.03
+2.59%
전일 마감가:
$1.15
열려 있는:
$1.16
하루 거래량:
110.94K
Relative Volume:
0.39
시가총액:
$13.31M
수익:
$28.74M
순이익/손실:
$-31.60M
주가수익비율:
-0.2283
EPS:
-5.0805
순현금흐름:
$-19.30M
1주 성능:
+0.00%
1개월 성능:
+0.87%
6개월 성능:
-23.68%
1년 성능:
-64.42%
1일 변동 폭
$1.1523
$1.19
1주일 범위
$1.15
$1.21
52주 변동 폭
$1.06
$5.50
바이오나노 지노믹스 Stock (BNGO) Company Profile
명칭
Bionano Genomics Inc
전화
(858) 888-7600
주소
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.16 | 13.31M | 28.74M | -31.60M | -19.30M | -5.0805 |
ISRG
Intuitive Surgical Inc
|
402.18 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
141.61 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.14 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.42 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
186.29 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
바이오나노 지노믹스 Stock (BNGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-12 | 재개 | BTIG Research | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2021-06-16 | 개시 | BTIG Research | Buy |
| 2020-09-24 | 개시 | Ladenburg Thalmann | Buy |
| 2020-04-08 | 개시 | Oppenheimer | Outperform |
모두보기
바이오나노 지노믹스 주식(BNGO)의 최신 뉴스
Bionano Genomics Keeps Penny Stock Risk In Focus - Kalkine Media
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders - The Manila Times
Infertility gene clues: 13 studies find hidden variants with Bionano mapping - Stock Titan
BNGO News | BIONANO GENOMICS INC (NASDAQ:BNGO) - ChartMill
Bionano Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Bionano Genomics (BNGO) upgraded to buy: What does it mean for the stock? - MSN
Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
BioNano Genomics Announces Resignation of Chief Medical Officer - The Globe and Mail
Bionano Genomics (NASDAQ: BNGO) Chief Medical Officer to step down - Stock Titan
Bionano Genomics, Inc. Announces Resignation of Alka Chaubey as Chief Medical Officer, Effective July 5, 2026 - marketscreener.com
Bionano appoints board chairman as interim CEO - Investing.com
Bionano Genomics (BNGO) CMO has 24 vested shares withheld for tax obligations - Stock Titan
Bionano Genomics (BNGO) counsel has 24 shares withheld for RSU taxes - Stock Titan
Bionano Genomics (BNGO) officer reports 7-share tax withholding - Stock Titan
Bionano (BNGO) Q1 2026 Earnings Transcript - The Globe and Mail
Bionano Genomics names board chair Luderer interim CEO - MSN
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and BioLife Solutions (BLFS) - The Globe and Mail
Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
BioNano Genomics Retires Secured Debt, Boosts Flexibility - The Globe and Mail
Bionano Genomics Fully Retires $20 Million Secured Debt, Boosting Financial Flexibility for Future Growth 1 - Minichart
Why fast-paced mover Bionano Genomics (BNGO) is a great choice for value investors - MSN
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - Yahoo Finance
Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures - The Manila Times
Bionano fully retires $20M senior secured convertible debentures, frees secured assets - TradingView
Bionano Genomics (NASDAQ: BNGO) eliminates $20M secured debt load - Stock Titan
Bionano clears $20M in secured debt, gains new flexibility - Stock Titan
BNGO Stock Price, Quote & Chart | BIONANO GENOMICS INC (NASDAQ:BNGO) - ChartMill
Bionano Genomics (BNGO) Achieves Breakthrough in T-ALL Detection - GuruFocus
Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia - The Manila Times
Leukemia study: genome scan finds abnormalities in 97.8% of T-ALL cases - Stock Titan
Bionano Genomics Q4 2026 earnings preview - MSN
Optical Genome Mapping Market Size, Share, Growth, Analysis, 2034 - Straits Research
BNGO Q1 2026 Earnings: Narrowing Losses Beat Estimates, but Stock Declines on Uncertain OutlookEarnings Power Value - newsline.com
Earnings call transcript: Bionano Genomics sees Q1 revenue growth, stock edges up - Investing.com Canada
Q1 2026 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
Bionano outlines $30M-$33M 2026 revenue guidance as it expects flow cell supply to improve - MSN
Bionano Genomics, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-05-16 - Seeking Alpha
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2026 Earnings Call Transcript - Insider Monkey
Bionano Genomics shareholders elect directors and approve proposals at annual meeting - Investing.com Nigeria
Bionano Genomics (NASDAQ: BNGO) director awarded 9,149 options - Stock Titan
Bionano Genomics (BNGO) director granted 9,149 stock options at $1.19 - Stock Titan
Bionano Genomics (BNGO) director awarded 9,149 stock options vesting over 12 months - Stock Titan
Bionano Genomics (BNGO) director receives grant of 9,149 stock options at $1.19 - Stock Titan
Bionano Genomics (BNGO) director receives stock option grant for 9,149 shares - Stock Titan
BioNano Genomics Stockholders Approve 2026 Annual Meeting Proposals - TipRanks
Bionano Genomics shareholders elect directors and approve proposals at annual meeting By Investing.com - Investing.com South Africa
Bionano Genomics 1Q Rev $6.7M >BNGO - Moomoo
바이오나노 지노믹스 (BNGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.23%
자본화:
|
볼륨(24시간):